NR1H4 and hyperlipidemia: In Apo lipoprotein E-knock out mice, FXR activation by BAs or synthetic ligands inhibited the expression of sterol regulatory element binding protein-1c in the liver, thus promoting cholesterol and triglyceride breakdown in the liver, which subsequently prevents hyperlipidemia.